The Journal of Thoracic and Cardiovascular Surgery
Volume 137, Issue 6 , Pages 1508-1514, June 2009

Selective phosphodiesterase-5 inhibition reduces neointimal hyperplasia in rat carotid arteries after surgical endarterectomy

  • Kristóf Hirschberg, MD

      Affiliations

    • Department of Cardiac Surgery, University of Heidelberg, Heidelberg, Germany
    • Department of Cardiovascular Surgery, Semmelweis University, Budapest, Hungary
    • Corresponding Author InformationAddress for reprints: Kristóf Hirschberg, MD, Experimental Laboratory of Cardiac Surgery, University of Heidelberg, Im Neuenheimer Feld 326, OG 2, 69120 Heidelberg, Germany.
    • ,
  • Tamás Radovits, MD, PhD

      Affiliations

    • Department of Cardiac Surgery, University of Heidelberg, Heidelberg, Germany
    • Department of Cardiovascular Surgery, Semmelweis University, Budapest, Hungary
    • ,
  • Sivakkanan Loganathan

      Affiliations

    • Department of Cardiac Surgery, University of Heidelberg, Heidelberg, Germany
    • ,
  • László Entz, MD, PhD

      Affiliations

    • Department of Cardiovascular Surgery, Semmelweis University, Budapest, Hungary
    • ,
  • Carsten J. Beller, MD

      Affiliations

    • Department of Cardiac Surgery, University of Heidelberg, Heidelberg, Germany
    • ,
  • Marie–Luise Gross, MD

      Affiliations

    • Department of Pathology, University of Heidelberg, Heidelberg, Germany
    • ,
  • Peter Sandner, PhD

      Affiliations

    • Bayer HealthCare, Wuppertal, Germany
    • ,
  • Matthias Karck, MD

      Affiliations

    • Department of Cardiac Surgery, University of Heidelberg, Heidelberg, Germany
    • ,
  • Gábor Szabó, MD, PhD

      Affiliations

    • Department of Cardiac Surgery, University of Heidelberg, Heidelberg, Germany

Received 23 July 2008; received in revised form 16 September 2008; accepted 13 October 2008. published online 11 February 2009.

Objective

Long-term results of surgical vessel reconstruction are compromised by restenosis caused by neointimal hyperplasia. Recent studies suggest that reduced cyclic guanosine monophosphate signaling is associated with neointima formation. In a rat model of endarterectomy, we investigated the effect of pharmacologic inhibition of cyclic guanosine monophosphate degradation on neointima formation by using the selective phosphodiesterase-5 inhibitor vardenafil.

Methods

Carotid endarterectomy was performed in male Sprague–Dawley rats by means of incision of the right common carotid artery with removal of intima. Four groups were studied: unoperated control rats (n = 4), sham-operated rats (n = 9), control rats with endarterectomy (n = 9), or endarterectomized rats treated with vardenafil (10 mg/kg/day) postoperatively (n = 9). After 3 weeks, vessel compartment areas were measured by means of conventional microscopy with hematoxylin and eosin staining. Immunohistochemical analysis was performed to confirm neointima formation and the local cyclic guanosine monophosphate content. Plasma levels of cyclic guanosine monophosphate were determined by means of enzyme immunoassay. Student's t test was used for statistical evaluation.

Results

Immunohistochemical analysis demonstrated intensive staining for transforming growth factor β1 and α-smooth muscle actin in the control neointima. Vardenafil significantly reduced the stenosis grade (24.64% ± 7.46% vs 54.12% ± 10.30% in the control group, P < .05) and expression of transforming growth factor β1, as well as α-smooth muscle actin, in the neointima. The immunohistochemical score for cyclic guanosine monophosphate was higher in the treated neointima (4.80 ± 0.76 vs 2.84 ± 0.40 in the control group, P < .05), and increased plasma cyclic guanosine monophosphate levels were found by means of enzyme immunoassay as well (84.65 ± 12.77 pmol/mL vs 43.50 ± 3.30 pmol/mL in the control group, P < .05).

Conclusions

Treatment with vardenafil can be considered a new possibility to prevent neointimal hyperplasia after endarterectomy.

Abbreviations and Acronyms: cGMP, cyclic guanosine monophosphate, NO, nitric oxide, PARP, peroxynitrite–poly (adenosine diphosphate–ribose) polymerase, PKG, protein kinase G, SMC, smooth muscle cell, TGF, transforming growth factor, TUNEL, terminal deoxynucleotidyl transferase–mediated dUTP-biotin nick end labeling

CTSNet classification: 33

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 This work was partially supported by Bayer HealthCare, Wuppertal, Germany. Peter Sandner, PhD, is an employee of Bayer HealthCare, Wuppertal, Germany.

PII: S0022-5223(08)01723-6

doi:10.1016/j.jtcvs.2008.10.016

The Journal of Thoracic and Cardiovascular Surgery
Volume 137, Issue 6 , Pages 1508-1514, June 2009

Article Tools

* Image Usage & Resolution